3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow vaxigrip: new trials by email Literature Review of vaxigrip trials Research Report on vaxigrip
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine Vi-DT, Typhim Vi®, VAXIGRIP® - Typhoid | Phase 1 | Completed | International Vaccine Institute | 144 | 2016-05-19 | 2020-04-28 |
| Routes of Immunization and Flu Immune Responses INTANZA® 15, Vaxigrip®, INTANZA® 15 T - Influenza | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 60 | 2012-10-01 | 2013-08-05 |
| A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) Injected to Elderly Volunteers Multimeric-001 250 mcg, Adjuvanted Multimeric-001 250mcg, Placebo - Influenza | Phase 1 / Phase 2 | Completed | BiondVax Pharmaceuticals ltd. | 60 | 2009-09-01 | 2012-07-31 |
Influenza, Human (2) · Typhoid Fever (1)
Assistance Publique - Hôpitaux de Paris (1) · BiondVax Pharmaceuticals ltd. (1) · International Vaccine Institute (1)
France (1) · Israel (1)
Jacob Atsmon, MD (1) · Maria Rosario Capeding, MD (1)